Skip to content

Evaluation of impact and efficacy in a public psychiatric service of a device using micro-current applied at the ear lobe, for major, mild and minor depressive disorders, and generalized anxiety disorders.

Evaluation of impact and efficacy in a public psychiatric service of a device using micro-current applied at the ear lobe, for major, mild and minor depressive disorders, and generalized anxiety disorders.

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12609000638235
Acronym
CN1
Enrollment
24
Registered
2009-07-30
Start date
2008-01-07
Completion date
2010-12-31
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The aim of this study is evaluate the impact and efficacy in a public psychiatric service of a device using micro-current applied at the ear lobe, for major, mild and minor depressive disorder, and generalized anxiety disorders, assessed with Symptomatic Check List (SCL-90R) and Hamilton Depression Rating Scale (HDRS)

Interventions

Evaluation of impact and efficacy in a public psychiatric service of a device using micro-current applied at the ear lobe, for major, mild and minor depressive disorders, and generalized anxiety disorders. The intervention comprises: A cycle of auricular treatment protocol with Radioelectric Asymetric Conveyer (REAC). The REAC is a Radioelectric medical device. The REAC protocol used, called Neuro Psycho Physical Optimization (ONPF), involves the application of a probe of the REAC on specific po

Evaluation of impact and efficacy in a public psychiatric service of a device using micro-current applied at the ear lobe, for major, mild and minor depressive disorders, and generalized anxiety disorders. The intervention comprises: A cycle of auricular treatment protocol with Radioelectric Asymetric Conveyer (REAC). The REAC is a Radioelectric medical device. The REAC protocol used, called Neuro Psycho Physical Optimization (ONPF), involves the application of a probe of the REAC on specific points of the auricular pavilion for an activation time of roughly 500 mms. The ONPF protocol is activated in a precise sequence on seven auricular points. The protocol envisages 18 sessions lasting 3.5 seconds each (7X 500 mms) on alternating days, for eight (8) weeks. Assessment, at baseline and immediately at the end of treatment, with Symptomatic Check List (SCL-90R) and Hamilton Test

Sponsors

Istituto Rinaldi Fontani
Lead SponsorCharities/Societies/Foundations

Study design

Allocation
Non-randomised trial
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Subjects without organic diseases, over 18 years old, female and male, with diagnosis of major, mild and minor depressive disorder or generalized anxiety disorders.

Exclusion criteria

Subjects with neurological disease, severe psychiatric disease, psychosis, subjects with antipsychotic medication.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026